Reify Health, Inc. Overview
Pro stress-test →Reify Health's technology uses optimization software to deliver clinical study research directly to healthcare providers and patients through partnerships with pharmaceutical companies, healthcare organizations and research sites worldwide. Founded in 2012 and based in Boston, Massachusetts, the company has scaled into a clinical trials infrastructure leader serving the biopharma and healthcare ecosystem.
Strategic Profile
Pro stress-test →Through its business entities, OneStudyTeam and Care Access, the company provides best-in-class trial optimization software and transformative clinical trial infrastructure that delivers research directly to more healthcare providers, communities, and patients wherever they are. Reify Health became a unicorn in 2021 and maintains focus on accelerating clinical trial operations while expanding access to underserved populations.
Competitive Landscape
Pro stress-test →Competitors include ObvioHealth, Pentavere, Aetion, Castor, Science 37 and others. Top competitors include companies like Medidata, IQVIA and Verily. Reify Health differentiates through its dual focus on trial optimization software and infrastructure-level connectivity across disparate clinical trial stakeholders.
Industry Context
Reify Health, Inc. operates in Clinical Trial Technology / Healthcare IT.
Key facts
Founded: 2012 · Headquarters: Boston, Massachusetts, US · Employees: 73 (as of February 2026) · Revenue: N/A · Market cap: $4.8B (valuation, November 2024)